(a).
Prognostic parameters | EGFR | P value | CK5 | P value | ||
---|---|---|---|---|---|---|
Positive | Negative | Positive | Negative | |||
Age | ||||||
≤40 | 13 | 1 | >0.05 | 7 | 7 | >0.05 |
41–50 | 8 | 2 | 6 | 4 | ||
>50 | 10 | 2 | 9 | 3 | ||
| ||||||
Tumor size (cm) | ||||||
≤2 | 11 | 2 | >0.05 | 9 | 4 | >0.05 |
2.1–5 | 15 | 3 | 11 | 7 | ||
>5 | 5 | 0 | 2 | 3 | ||
| ||||||
Histopathological diagnosis | ||||||
IDC, NOS | 24 | 5 | >0.05 | 17 | 12 | >0.05 |
Mucinous carcinoma | 2 | 0 | 1 | 1 | ||
Metaplastic carcinoma | 1 | 0 | 1 | 0 | ||
Medullary carcinoma | 3 | 0 | 3 | 0 | ||
Mixed ductal-lobular carcinoma | 1 | 0 | 0 | 1 | ||
| ||||||
Tumour grades | ||||||
Grade I | 4 | 1 | >0.05 | 2 | 3 | 0.052 |
Grade II | 17 | 0 | 8 | 9 | ||
Grade III | 10 | 4 | 12 | 2 |